Haiyan Zheng, S. Roy, Amenah Soherwardy, S. Rahman, M. Kuruc
{"title":"基质液体活检™-癌症全身反应的蛋白质组学模型","authors":"Haiyan Zheng, S. Roy, Amenah Soherwardy, S. Rahman, M. Kuruc","doi":"10.15406/mojpb.2017.06.00188","DOIUrl":null,"url":null,"abstract":"The advancements in “nextgen” and rapid genome sequencing have spawned new companies for liquid biopsy products and services that are quick, minimally invasive and that allow clinicians to monitor the course of therapy and to forecast recurrent disease. While these are certainly exciting prospects, challenges remain as genomic instability is a fundamental hallmark of cancer cells [1]. So in many respects, genomic driven approaches will always suffer the problem of shooting after a moving target.","PeriodicalId":18585,"journal":{"name":"MOJ proteomics & bioinformatics","volume":"8 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Stroma liquid biopsy™-a proteomic model of the systemic response to cancer\",\"authors\":\"Haiyan Zheng, S. Roy, Amenah Soherwardy, S. Rahman, M. Kuruc\",\"doi\":\"10.15406/mojpb.2017.06.00188\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The advancements in “nextgen” and rapid genome sequencing have spawned new companies for liquid biopsy products and services that are quick, minimally invasive and that allow clinicians to monitor the course of therapy and to forecast recurrent disease. While these are certainly exciting prospects, challenges remain as genomic instability is a fundamental hallmark of cancer cells [1]. So in many respects, genomic driven approaches will always suffer the problem of shooting after a moving target.\",\"PeriodicalId\":18585,\"journal\":{\"name\":\"MOJ proteomics & bioinformatics\",\"volume\":\"8 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-09-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"MOJ proteomics & bioinformatics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15406/mojpb.2017.06.00188\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"MOJ proteomics & bioinformatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/mojpb.2017.06.00188","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Stroma liquid biopsy™-a proteomic model of the systemic response to cancer
The advancements in “nextgen” and rapid genome sequencing have spawned new companies for liquid biopsy products and services that are quick, minimally invasive and that allow clinicians to monitor the course of therapy and to forecast recurrent disease. While these are certainly exciting prospects, challenges remain as genomic instability is a fundamental hallmark of cancer cells [1]. So in many respects, genomic driven approaches will always suffer the problem of shooting after a moving target.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
